- Blue Venture Fund
These relationships help us explore how to implement emerging technologies and drive the commercialization of innovative solutions Through the BVF platform, Blue Plans gain access to technologies, innovations, and solutions through our portfolio companies and pipeline opportunities
- Sandbox Industries
The Blue Venture Funds (BVF), a unique collaboration among Blue Cross Blue Shield (BCBS) companies, the Blue Cross Blue Shield Association (BCBSA) and Sandbox, is owned, governed and capitalized by participating Blue Plans and affiliates
- BVF Partners investment portfolio | PitchBook
Founded in 1993, BVF Partners is a fundamental equity hedge fund manager based in San Francisco, California The firm primarily invests in companies operating in the biotechnology sector
- BVF INC Top 13F Holdings - WhaleWisdom. com
BVF Partners L P (“BVF” or “we”) is an asset management firm that generally invests in biotechnology companies BVF is a Delaware limited partnership that commenced operations BVF currently provides investment advice to the BVF Funds, the Single Investor Fund and the Managed Accounts
- BVF - 2025 Investor Profile, Portfolio, Team Investment Trends - Tracxn
BVF is a venture capital firm founded in 2008 It is primarily based out of Chicago, United States As of Aug 2025, BVF is an active investor, having invested in 72 companies, with 3 new investments in the last 12 months It primarily invests in Series A round in United States based startups
- BVF Partners - Private Equity List
Since its inception in 1993, BVF has strived to build concentrated, long-term investments in small-cap biotechnology companies while performing rigorous diligence and on-going monitoring of itsinvestments
- BVF Partners Portfolio | Mark Lampert 13F Holdings Trades
Heatmaps of the top 13f holdings and a list of the largest trades made by BVF Partners, the hedge fund managed by Mark Lampert
- BVF Partners - Massinvestor Venture Capital and Private Equity Database
BVF Partners L P is a San Francisco-based private investment partnership specializing in fundamentally-driven public biotechnology investments
|